Blue Barn Wealth, LLC Astrazeneca PLC Transaction History

Blue Barn Wealth, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 17, 2024	BUY	$76.67 - $87.62 $10,427 - $11,916	136 Added 4.04%	3,504 $273,000
Q2 2024 Aug 05, 2024	BUY	$66.81 - $80.83 $22,114 - $26,754	331 Added 10.9%	3,368 $262,000
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $793 - $904	13 Added 0.43%	3,037 $205,000
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $187,155 - $209,502	3,024 New	3,024 $203,000

1,351

489M

5.88M

4.1M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $228B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Blue Barn Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Blue Barn Wealth, LLC with notifications on news.